Welcome to our dedicated page for OCLT news (Ticker: OCLT), a resource for investors and traders seeking the latest updates and insights on OCLT stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OCLT's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OCLT's position in the market.
OceanLight Acquisition Corporation (Nasdaq: OCLTU/OCLT) priced its initial public offering of 10,000,000 units at $10.00 per unit, for an IPO size of approximately $100 million. Each unit includes one ordinary share, one right to receive one-fourth of one ordinary share upon completion of the initial business combination, and one redeemable warrant.
Each whole warrant allows the purchase of one ordinary share at $11.50, subject to adjustments. The units are expected to begin trading on the Nasdaq Global Market under the symbol OCLTU on August 7, 2026, with the IPO expected to close on August 10, 2026, subject to customary conditions. After separation, the ordinary shares, rights and warrants are expected to trade under OCLT, OCLTR and OCLTW, respectively. The underwriters have a 45‑day option to buy up to 1,500,000 additional units to cover over‑allotments.